Avanos Medical Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $20.01
- Today's High:
- $20.565
- Open Price:
- $20.32
- 52W Low:
- $19.32
- 52W High:
- $31.99
- Prev. Close:
- $20.39
- Volume:
- 441866
Company Statistics
- Market Cap.:
- $1.15 billion
- Book Value:
- 27.869
- Revenue TTM:
- $814.30 million
- Operating Margin TTM:
- 10.03%
- Gross Profit TTM:
- $450 million
- Profit Margin:
- 5.48%
- Return on Assets TTM:
- 2.92%
- Return on Equity TTM:
- 3.49%
Company Profile
Avanos Medical Inc had its IPO on 2014-10-21 under the ticker symbol AVNS.
The company operates in the Healthcare sector and Medical Devices industry. Avanos Medical Inc has a staff strength of 4,044 employees.
Stock update
Shares of Avanos Medical Inc opened at $20.32 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $20.01 - $20.57, and closed at $20.14.
This is a -1.23% slip from the previous day's closing price.
A total volume of 441,866 shares were traded at the close of the day’s session.
In the last one week, shares of Avanos Medical Inc have slipped by -6.02%.
Avanos Medical Inc's Key Ratios
Avanos Medical Inc has a market cap of $1.15 billion, indicating a price to book ratio of 1.0013 and a price to sales ratio of 1.5359.
In the last 12-months Avanos Medical Inc’s revenue was $814.30 million with a gross profit of $450 million and an EBITDA of $130.40 million. The EBITDA ratio measures Avanos Medical Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Avanos Medical Inc’s operating margin was 10.03% while its return on assets stood at 2.92% with a return of equity of 3.49%.
In Q1, Avanos Medical Inc’s quarterly earnings growth was a positive 50.6% while revenue growth was a negative 2.9%.
Avanos Medical Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 25.625
- PEG
Its diluted EPS in the last 12-months stands at $0.96 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Avanos Medical Inc’s profitability.
Avanos Medical Inc stock is trading at a EV to sales ratio of 1.8249 and a EV to EBITDA ratio of 12.3503. Its price to sales ratio in the trailing 12-months stood at 1.5359.
Avanos Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $1.73 billion
- Total Liabilities
- $158.50 million
- Operating Cash Flow
- $-4000000.00
- Capital Expenditure
- $4 million
- Dividend Payout Ratio
- 0%
Avanos Medical Inc ended 2024 with $1.73 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.73 billion while shareholder equity stood at $1.30 billion.
Avanos Medical Inc ended 2024 with $25.10 million in deferred long-term liabilities, $158.50 million in other current liabilities, 500000.00 in common stock, $-253100000.00 in retained earnings and $821.50 million in goodwill. Its cash balance stood at $95.70 million and cash and short-term investments were $95.70 million. The company’s total short-term debt was $18,300,000 while long-term debt stood at $204.70 million.
Avanos Medical Inc’s total current assets stands at $453.80 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $142.70 million compared to accounts payable of $59.60 million and inventory worth $200.00 million.
In 2024, Avanos Medical Inc's operating cash flow was $-4000000.00 while its capital expenditure stood at $4 million.
Comparatively, Avanos Medical Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $20.14
- 52-Week High
- $31.99
- 52-Week Low
- $19.32
- Analyst Target Price
- $29
Avanos Medical Inc stock is currently trading at $20.14 per share. It touched a 52-week high of $31.99 and a 52-week low of $31.99. Analysts tracking the stock have a 12-month average target price of $29.
Its 50-day moving average was $23.28 and 200-day moving average was $26.45 The short ratio stood at 3.34 indicating a short percent outstanding of 0%.
Around 301.4% of the company’s stock are held by insiders while 9687.9% are held by institutions.
Frequently Asked Questions About Avanos Medical Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy and OrthogenRx’s knee osteoarthritis pain relief injection products. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.